Table 1.
Clinical characteristics of patients
| Clinical characteristics | Frozen samples (N = 108) | Paraffin samples (N = 132) | All (N = 240) |
|---|---|---|---|
| Age | 48.12 ± 11.47 | 53.32 ± 8.79 | 50.98 ± 10.40 |
| FIGO stage | |||
| I–II | 23 | – | 23 |
| III–IV | 85 | 132 | 217 |
| Grade (serous) | |||
| 3 | 74 | 132 | 206 |
| 1 | 17 | – | 17 |
| Grade (mucinous and endometrioid) | |||
| 3 | 11 | – | 11 |
| 2 | 1 | – | 1 |
| 1 | 5 | – | 5 |
| Histology types | |||
| Serous | 91 | 132 | 223 |
| Mucinous | 14 | – | 14 |
| Endometrioid | 3 | – | 3 |
| Surgical debulking | |||
| Optimal | 76 | 96 | 172 |
| Suboptimal | 32 | 36 | 68 |
| Chemotherapy outcome | |||
| Chemoresistant | 55 | 56 | 111 |
| Chemosensitive | 53 | 76 | 129 |
| Postoperative chemotherapy scheme | |||
| TP (paclitaxel plus cisplatin) | 57 | 58 | 115 |
| TC (paclitaxel plus carboplatin) | 51 | 74 | 125 |